215 related articles for article (PubMed ID: 30638972)
1. The Tumor Suppressor PALB2: Inside Out.
Ducy M; Sesma-Sanz L; Guitton-Sert L; Lashgari A; Gao Y; Brahiti N; Rodrigue A; Margaillan G; Caron MC; Côté J; Simard J; Masson JY
Trends Biochem Sci; 2019 Mar; 44(3):226-240. PubMed ID: 30638972
[TBL] [Abstract][Full Text] [Related]
2. Exploring the roles of PALB2 at the crossroads of DNA repair and cancer.
Pauty J; Rodrigue A; Couturier A; Buisson R; Masson JY
Biochem J; 2014 Jun; 460(3):331-42. PubMed ID: 24870022
[TBL] [Abstract][Full Text] [Related]
3. The Role of PALB2 in the DNA Damage Response and Cancer Predisposition.
Nepomuceno TC; De Gregoriis G; de Oliveira FMB; Suarez-Kurtz G; Monteiro AN; Carvalho MA
Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28858227
[TBL] [Abstract][Full Text] [Related]
4. Ablation of the Brca1-Palb2 Interaction Phenocopies Fanconi Anemia in Mice.
Park D; Bergin SM; Jones D; Ru P; Koivisto CS; Jeon YJ; Sizemore GM; Kladney RD; Hadjis A; Shakya R; Ludwig T
Cancer Res; 2020 Oct; 80(19):4172-4184. PubMed ID: 32732220
[TBL] [Abstract][Full Text] [Related]
5. Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2.
Xia B; Sheng Q; Nakanishi K; Ohashi A; Wu J; Christ N; Liu X; Jasin M; Couch FJ; Livingston DM
Mol Cell; 2006 Jun; 22(6):719-729. PubMed ID: 16793542
[TBL] [Abstract][Full Text] [Related]
6. PALB2: the hub of a network of tumor suppressors involved in DNA damage responses.
Park JY; Zhang F; Andreassen PR
Biochim Biophys Acta; 2014 Aug; 1846(1):263-75. PubMed ID: 24998779
[TBL] [Abstract][Full Text] [Related]
7. PALB2/FANCN: recombining cancer and Fanconi anemia.
Tischkowitz M; Xia B
Cancer Res; 2010 Oct; 70(19):7353-9. PubMed ID: 20858716
[TBL] [Abstract][Full Text] [Related]
8. Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer.
Reid S; Schindler D; Hanenberg H; Barker K; Hanks S; Kalb R; Neveling K; Kelly P; Seal S; Freund M; Wurm M; Batish SD; Lach FP; Yetgin S; Neitzel H; Ariffin H; Tischkowitz M; Mathew CG; Auerbach AD; Rahman N
Nat Genet; 2007 Feb; 39(2):162-4. PubMed ID: 17200671
[TBL] [Abstract][Full Text] [Related]
9. Emergence of a DNA-damage response network consisting of Fanconi anaemia and BRCA proteins.
Wang W
Nat Rev Genet; 2007 Oct; 8(10):735-48. PubMed ID: 17768402
[TBL] [Abstract][Full Text] [Related]
10. Inducibility of nuclear Rad51 foci after DNA damage distinguishes all Fanconi anemia complementation groups from D1/BRCA2.
Godthelp BC; Wiegant WW; Waisfisz Q; Medhurst AL; Arwert F; Joenje H; Zdzienicka MZ
Mutat Res; 2006 Feb; 594(1-2):39-48. PubMed ID: 16154163
[TBL] [Abstract][Full Text] [Related]
11. Antiparallel Coiled-Coil Interactions Mediate the Homodimerization of the DNA Damage-Repair Protein PALB2.
Song F; Li M; Liu G; Swapna GVT; Daigham NS; Xia B; Montelione GT; Bunting SF
Biochemistry; 2018 Nov; 57(47):6581-6591. PubMed ID: 30289697
[TBL] [Abstract][Full Text] [Related]
12. Murine models for familial pancreatic cancer: Histopathology, latency and drug sensitivity among cancers of Palb2, Brca1 and Brca2 mutant mouse strains.
Park D; Shakya R; Koivisto C; Pitarresi JR; Szabolcs M; Kladney R; Hadjis A; Mace TA; Ludwig T
PLoS One; 2019; 14(12):e0226714. PubMed ID: 31877165
[TBL] [Abstract][Full Text] [Related]
13. Fanconi anemia is associated with a defect in the BRCA2 partner PALB2.
Xia B; Dorsman JC; Ameziane N; de Vries Y; Rooimans MA; Sheng Q; Pals G; Errami A; Gluckman E; Llera J; Wang W; Livingston DM; Joenje H; de Winter JP
Nat Genet; 2007 Feb; 39(2):159-61. PubMed ID: 17200672
[TBL] [Abstract][Full Text] [Related]
14. Assessment of PALB2 as a candidate melanoma susceptibility gene.
Aoude LG; Xu M; Zhao ZZ; Kovacs M; Palmer JM; Johansson P; Symmons J; Trent JM; Martin NG; Montgomery GW; Brown KM; Hayward NK
PLoS One; 2014; 9(6):e100683. PubMed ID: 24949998
[TBL] [Abstract][Full Text] [Related]
15. Coordination of the recruitment of the FANCD2 and PALB2 Fanconi anemia proteins by an ubiquitin signaling network.
Bick G; Zhang F; Meetei AR; Andreassen PR
Chromosoma; 2017 Jun; 126(3):417-430. PubMed ID: 27277787
[TBL] [Abstract][Full Text] [Related]
16. A Hypomorphic PALB2 Allele Gives Rise to an Unusual Form of FA-N Associated with Lymphoid Tumour Development.
Byrd PJ; Stewart GS; Smith A; Eaton C; Taylor AJ; Guy C; Eringyte I; Fooks P; Last JI; Horsley R; Oliver AW; Janic D; Dokmanovic L; Stankovic T; Taylor AM
PLoS Genet; 2016 Mar; 12(3):e1005945. PubMed ID: 26990772
[TBL] [Abstract][Full Text] [Related]
17. A global functional analysis of missense mutations reveals two major hotspots in the PALB2 tumor suppressor.
Rodrigue A; Margaillan G; Torres Gomes T; Coulombe Y; Montalban G; da Costa E Silva Carvalho S; Milano L; Ducy M; De-Gregoriis G; Dellaire G; Araújo da Silva W; Monteiro AN; Carvalho MA; Simard J; Masson JY
Nucleic Acids Res; 2019 Nov; 47(20):10662-10677. PubMed ID: 31586400
[TBL] [Abstract][Full Text] [Related]
18. Interaction with PALB2 Is Essential for Maintenance of Genomic Integrity by BRCA2.
Hartford SA; Chittela R; Ding X; Vyas A; Martin B; Burkett S; Haines DC; Southon E; Tessarollo L; Sharan SK
PLoS Genet; 2016 Aug; 12(8):e1006236. PubMed ID: 27490902
[TBL] [Abstract][Full Text] [Related]
19. [Fanconi anemia--genotoxic stress and senescence of hematopoietic stem cells].
Yamashita T; Oda T; Sekimoto T
Nihon Rinsho; 2008 Mar; 66(3):477-82. PubMed ID: 18330024
[TBL] [Abstract][Full Text] [Related]
20. PALB2 (partner and localizer of BRCA2).
Hanenberg H; Andreassen PR
Atlas Genet Cytogenet Oncol Haematol; 2018 Apr; 22(12):484-490. PubMed ID: 31413733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
